OTC Markets Group (OTCM) opened 2026 with Q1 revenue of US$30.4 million and basic EPS of US$0.60, alongside trailing twelve month revenue of US$115.4 million and basic EPS of US$2.68 that frame the latest quarter in a broader context. Over recent periods, revenue has moved from US$27.1 million in Q1 2025 to US$30.4 million in Q1 2026, while quarterly basic EPS has shifted from US$0.50 to US$0.60 over the same span. This sets up a story where investors can focus on how margins and earnings quality underpin the current income profile and ongoing growth debates.

See our full analysis for OTC Markets Group.

With the headline numbers on the table, the next step is to set these results against the leading narratives around OTC Markets Group to see which views are supported by the data and which are challenged by the latest margin and earnings trends.

Margins Hold Steady Around 27%

• On a trailing basis, OTC Markets Group reported net income of US$31.5 million on US$115.4 million of revenue, which works out to a 27.3% net margin compared with 26.1% a year earlier.
• Analysts' consensus view that platform expansion and higher value data products can support healthy profitability is partly reflected in this margin level, but there are a few points to consider:
  • Year over year, trailing earnings growth of 17.5% sits well ahead of the 1.8% per year pace over five years, showing recent performance has been stronger than the longer term trend.
  • At the same time, forecasts call for earnings growth of about 5% per year, which is lower than broader US market expectations, so the current 27.3% margin has to be weighed against more moderate growth forecasts.

Revenue Growth vs Forecast Pace

• Quarterly revenue moved from US$27.1 million in Q1 2025 to US$30.4 million in Q1 2026, while trailing twelve month revenue sits at US$115.4 million compared with US$102.98 million a year earlier, alongside an 8.9% per year revenue growth forecast mentioned in the analysis.
• Consensus narrative highlights growth in issuers and trading activity as a driver for recurring revenue, and the reported figures line up with that view, but with some important context:
  • The move in trailing revenue from about US$103.0 million to US$115.4 million is consistent with the idea that platform usage is increasing, yet the 8.9% forecast revenue growth rate is below the 11.4% expected for the US market.
  • Concerns in the consensus narrative about competitive pressure and issuer churn remain relevant, because if issuer numbers or trading volumes soften, it could make it harder to match or exceed those forecast growth rates.

Income Yield and Mixed Valuation Signals

• At a share price of US$56.00 and trailing EPS of US$2.68, the stock trades on a P/E of about 21x, against a DCF fair value of US$52.78 and an income return highlighted at a 5.27% dividend yield.
• Where the consensus narrative sees long term earnings potential from data monetization and 24 hour trading, the valuation and income profile give investors a few concrete checks:
  • The 21x P/E is below the broader US Capital Markets industry average of 42.8x, yet above the closer peer average of 18.8x, which means the stock sits between broader sector pricing and more direct competitors.
  • The DCF fair value of US$52.78 is lower than the current US$56.00 share price, so anyone focusing on cash flow based valuation will likely compare that gap with the 5.27% dividend yield and decide how much weight to place on income versus the DCF signal.

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for OTC Markets Group on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for OTC Markets Group on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If this mix of earnings strength, income yield, and valuation signals feels balanced but uncertain, it is a good moment to look directly at the underlying data and form your own view quickly. To see exactly what optimism in the market is focused on right now, take a closer look at the 4 key rewards.

See What Else Is Out There

OTC Markets Group shows solid profitability, but the DCF fair value below the current share price and slower forecast growth than the broader market raise valuation questions.

If you are unsure about paying up for this kind of earnings and income profile right now, compare it with stocks in the 51 high quality undervalued stocks that may offer a clearer value case based on your criteria.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.